KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to 0.38%.

  • Eli Lilly's Return on Capital Employed rose 1000.0% to 0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.38% for FY2024, which is 300.0% up from last year.
  • As of Q3 2025, Eli Lilly's Return on Capital Employed stood at 0.38%, which was up 1000.0% from 0.39% recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Return on Capital Employed ranged from a high of 0.39% in Q2 2025 and a low of 0.19% during Q1 2021
  • For the 5-year period, Eli Lilly's Return on Capital Employed averaged around 0.27%, with its median value being 0.26% (2022).
  • Per our database at Business Quant, Eli Lilly's Return on Capital Employed crashed by -600bps in 2023 and then soared by 1000bps in 2024.
  • Over the past 5 years, Eli Lilly's Return on Capital Employed (Quarter) stood at 0.22% in 2021, then rose by 17bps to 0.26% in 2022, then increased by 19bps to 0.3% in 2023, then rose by 9bps to 0.33% in 2024, then rose by 14bps to 0.38% in 2025.
  • Its Return on Capital Employed stands at 0.38% for Q3 2025, versus 0.39% for Q2 2025 and 0.35% for Q1 2025.